Article
Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer.
BMC cancer - 23 Nov 2012
Kristensen Lasse Sommer, Kjeldsen Tina Ellegaard, Hager Henrik, Hansen Lise Lotte
Abstract excerpt
BACKGROUND: Cancer is an extremely heterogeneous group of diseases traditionally categorized according to tissue of origin. However, even among patients with the same cancer subtype the cellular alterations at the molecular level are often very different. Several new therapies targeting specific molecular changes found in individual patients have initiated the era of personalized therapy and significantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
